CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
Key Takeaways:
CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO
The approval could have limited benefits for the company as the pandemic fades and other products are widely available
By Jony Ho